Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 16Burkitt Lymphoma 15Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Graft vs Host Disease 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Chronic-Phase 7Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Congenital Abnormalities 6Breast Neoplasms 6Blast Crisis 6Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Immunoblastic 5Dendritic Cell Sarcoma, Interdigitating 5Urinary Bladder Neoplasms 4

Interventions

Carboplatin 44Paclitaxel 43liposomal doxorubicin 23Topotecan 19Gemcitabine 18pembrolizumab 17Cyclophosphamide 17Bevacizumab 16Cisplatin 12niraparib 9olaparib 8fludarabine 7Taxes 7Docetaxel 7aldesleukin 6Nivolumab 6Doxorubicin 61-dodecylpyridoxal 6oregovomab 5fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5rucaparib 4durvalumab 4avelumab 4Surgical Procedures, Operative 4Melphalan 4Ipilimumab 4Interleukin-2 4Etoposide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ovarian Neoplasms × Methotrexate × Clear all
NCT01175772 2015-06-23

Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy

HaEmek Medical Center, Israel

Phase 2 Terminated
6 enrolled
Gynecologic

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡